GlassScriptPhysician profile
Daniel F Silver
NPI 1376535831
$16,760.55
in general payments reported to CMS, 2019-2025
45 companies · $4,147 in 2025
The $4,147 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,437 · 2022: $2,468 · 2023: $3,373 · 2024: $3,336 · 2025: $4,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $85.00 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,720.24 |
| Education | $85.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $4,717.65 | 2021-2025 | Provenge |
| Antares Pharma, INC. | $1,582.00 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $1,476.06 | 2021-2024 | Xiaflex, Aveed, Edex |
| Progenics Pharmaceuticals, INC. | $628.88 | 2021-2025 | Pylarify |
| Sumitomo Pharma America, INC. | $627.20 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $549.77 | 2021-2025 | Myrbetriq, Xtandi |
| Coloplast Corp | $536.07 | 2021-2025 | Titan, Speedicath, Luja Coude |
| Janssen Biotech, INC. | $512.41 | 2021-2025 | Erleada, Rybrevant, Carvykti |
| Myriad Genetic Laboratories, INC. | $507.29 | 2021-2024 | Prolaris |
| Blue Earth Diagnostics | $478.78 | 2021-2025 | Posluma |
| 180 Medical, INC. | $474.18 | 2021-2025 | Gentlecath, Gentlecath Glide |
| Pfizer INC. | $456.00 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $424.77 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Bayer Healthcare Pharmaceuticals INC. | $408.16 | 2021-2025 | |
| Abbvie INC. | $387.35 | 2021-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $307.44 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $279.98 | 2022-2025 | Jelmyto |
| Accord Healthcare, INC. | $257.63 | 2022-2025 | |
| Halozyme INC | $255.26 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $239.55 | 2021-2025 | Lynparza |
| Ferring Pharmaceuticals INC. | $237.67 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $185.40 | 2022-2025 | Ams 700, Ams 700 Cxr Rte Kit, Rezum Generator |
| Novartis Pharmaceuticals Corporation | $142.55 | 2024-2025 | |
| Axonics, INC. | $140.15 | 2022-2023 | Axonics |
| Teleflex LLC | $117.03 | 2021-2025 | Urolift, Barrigel |
| Immunitybio, INC. | $114.57 | 2025 | |
| Clarus Therapeutics INC. | $106.83 | 2021 | |
| Tempus Ai, INC | $78.23 | 2024 | Xt Cdx |
| Alnylam Pharmaceuticals INC. | $73.91 | 2021-2022 | |
| Tolmar, INC. | $62.10 | 2023-2024 | |
| Olympus America INC. | $46.45 | 2023-2024 | Itind System |
| Tolmar Pharmaceuticals, INC. | $43.83 | 2022 | |
| Procept Biorobotics Corporation | $43.15 | 2024 | Aquabeam System |
| C. R. Bard, INC. & Subsidiaries | $40.10 | 2025 | Bard Urinary Drainage Bag |
| Hollister Incorporated | $32.17 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $29.12 | 2025 | |
| Davol INC. | $28.28 | 2024 | Channel Drain |
| Inspire Medical Systems, INC. | $18.52 | 2025 | Inspire |
| Rochester Medical Corporation | $17.94 | 2021 | |
| Ambu INC. | $17.86 | 2023 | |
| Convatec INC. | $17.66 | 2021 | |
| Urovant Sciences INC | $17.46 | 2022 | |
| Bioprotect Medical, INC. | $15.30 | 2025 | Bioprotect Balloon Implant System |
| Acerus Pharmaceuticals Corporation | $14.11 | 2022 | |
| Photocure INC | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.